Search results for "drug treatment"

Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits

Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits

Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct symptoms, many cases have...
Diabetes Has a Golden Window, Too: Starting Treatment Within 3 Months Cuts Death Risk 69%

Diabetes Has a Golden Window, Too: Starting Treatment Within 3 Months Cuts Death Risk 69%

It is easy to assume that people with type 2 diabetes do not need to rush into treatment. Most patients have no serious symptoms in the early stages,...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
Stopping Beta-Blockers After Heart Attack Safe for Stable Patients, Korea-France Study Finds

Stopping Beta-Blockers After Heart Attack Safe for Stable Patients, Korea-France Study Finds

One medication many patients take long-term following a heart attack is a beta-blocker.
Recreating Autoimmune Diseases in Lab 'Mini Organs' Requires Immune Environment, Not Just Patient Cells

Recreating Autoimmune Diseases in Lab 'Mini Organs' Requires Immune Environment, Not Just Patient Cells

Even among individuals sharing a diagnosis of rheumatoid arthritis or systemic lupus erythematosus, disease progression...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal

Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
More Stem Cells Doesn't Mean Better Results: Why Cell Count Alone Falls Short

More Stem Cells Doesn't Mean Better Results: Why Cell Count Alone Falls Short

Following the box-office success of the film Spider-Man: Brand New Day, public attention has once again turned to...
Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits

Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits

The arrival of disease-modifying treatments capable of slowing Alzheimer’s progression has offered patients newfound...
Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study

Combination Therapy: Laennec Achieves Pain Relief with One-Fifth the Steroid Dose in Preclinical Study

An animal study has revealed that combining GC Green Cross Wellbeing’s human placental hydrolysate treatment, Laennec...
Korean Liver Experts Warn Against 'Oral Albumin': It Is Just Food, Not Medicine

Korean Liver Experts Warn Against 'Oral Albumin': It Is Just Food, Not Medicine

Driven by aggressive marketing on home-shopping channels, online marketplaces, and social media, "oral albumin"...